CODERE ONLINE LUXEMBOURG SA (CDRO) Fundamental Analysis & Valuation

NASDAQ:CDRO • LU2405144788

Current stock price

8.12 USD
+0.12 (+1.5%)
Last:

This CDRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CDRO Profitability Analysis

1.1 Basic Checks

  • CDRO had positive earnings in the past year.
  • CDRO had a positive operating cash flow in the past year.
  • CDRO had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CDRO reported negative operating cash flow in multiple years.
CDRO Yearly Net Income VS EBIT VS OCF VS FCFCDRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • CDRO has a Return On Assets (1.09%) which is comparable to the rest of the industry.
  • The Return On Equity of CDRO (3.73%) is comparable to the rest of the industry.
  • The Return On Invested Capital of CDRO (18.60%) is better than 89.68% of its industry peers.
Industry RankSector Rank
ROA 1.09%
ROE 3.73%
ROIC 18.6%
ROA(3y)-21.66%
ROA(5y)-43.55%
ROE(3y)-61.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDRO Yearly ROA, ROE, ROICCDRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • CDRO has a worse Profit Margin (0.25%) than 61.11% of its industry peers.
  • Looking at the Operating Margin, with a value of 2.48%, CDRO is doing worse than 76.19% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 86.01%, CDRO belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
  • CDRO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.48%
PM (TTM) 0.25%
GM 86.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y0.47%
CDRO Yearly Profit, Operating, Gross MarginsCDRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. CDRO Health Analysis

2.1 Basic Checks

  • CDRO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for CDRO has been increased compared to 1 year ago.
  • The number of shares outstanding for CDRO has been increased compared to 5 years ago.
  • Compared to 1 year ago, CDRO has a worse debt to assets ratio.
CDRO Yearly Shares OutstandingCDRO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRO Yearly Total Debt VS Total AssetsCDRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • CDRO has an Altman-Z score of 6.38. This indicates that CDRO is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.38, CDRO belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
  • The Debt to FCF ratio of CDRO is 0.68, which is an excellent value as it means it would take CDRO, only 0.68 years of fcf income to pay off all of its debts.
  • CDRO has a better Debt to FCF ratio (0.68) than 89.68% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that CDRO is not too dependend on debt financing.
  • CDRO has a better Debt to Equity ratio (0.45) than 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 0.68
Altman-Z 6.38
ROIC/WACC2.46
WACC7.56%
CDRO Yearly LT Debt VS Equity VS FCFCDRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • CDRO has a Current Ratio of 1.40. This is a normal value and indicates that CDRO is financially healthy and should not expect problems in meeting its short term obligations.
  • CDRO has a better Current ratio (1.40) than 66.67% of its industry peers.
  • CDRO has a Quick Ratio of 1.40. This is a normal value and indicates that CDRO is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CDRO (1.40) is better than 70.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
CDRO Yearly Current Assets VS Current LiabilitesCDRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. CDRO Growth Analysis

3.1 Past

  • CDRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.61%, which is quite impressive.
  • Looking at the last year, CDRO shows a quite strong growth in Revenue. The Revenue has grown by 16.03% in the last year.
  • Measured over the past years, CDRO shows a very strong growth in Revenue. The Revenue has been growing by 26.65% on average per year.
EPS 1Y (TTM)126.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1133.93%
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.71%
Revenue growth 5Y26.65%
Sales Q2Q%-0.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 214.14% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CDRO will show a small growth in Revenue. The Revenue will grow by 5.64% on average per year.
EPS Next Y350%
EPS Next 2Y487.37%
EPS Next 3Y214.14%
EPS Next 5YN/A
Revenue Next Year5.03%
Revenue Next 2Y5.88%
Revenue Next 3Y5.64%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CDRO Yearly Revenue VS EstimatesCDRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CDRO Yearly EPS VS EstimatesCDRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

3

4. CDRO Valuation Analysis

4.1 Price/Earnings Ratio

  • CDRO is valuated quite expensively with a Price/Earnings ratio of 406.00.
  • CDRO's Price/Earnings ratio is a bit more expensive when compared to the industry. CDRO is more expensive than 65.08% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, CDRO is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 21.21, the valuation of CDRO can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CDRO.
  • When comparing the Price/Forward Earnings ratio of CDRO to the average of the S&P500 Index (23.84), we can say CDRO is valued inline with the index average.
Industry RankSector Rank
PE 406
Fwd PE 21.21
CDRO Price Earnings VS Forward Price EarningsCDRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CDRO is valued a bit more expensive than 78.57% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CDRO is valued a bit cheaper than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.26
EV/EBITDA 33.03
CDRO Per share dataCDRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CDRO's earnings are expected to grow with 214.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)N/A
EPS Next 2Y487.37%
EPS Next 3Y214.14%

0

5. CDRO Dividend Analysis

5.1 Amount

  • CDRO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CDRO Fundamentals: All Metrics, Ratios and Statistics

CODERE ONLINE LUXEMBOURG SA

NASDAQ:CDRO (3/13/2026, 8:14:31 PM)

8.12

+0.12 (+1.5%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26
Earnings (Next)05-14
Inst Owners12.01%
Inst Owner Change-1.72%
Ins Owners0.79%
Ins Owner ChangeN/A
Market Cap369.95M
Revenue(TTM)306.03M
Net Income(TTM)761.00K
Analysts78
Price Target11.05 (36.08%)
Short Float %2.28%
Short Ratio25.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.82%
Min Revenue beat(2)-7.01%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-7.01%
Max Revenue beat(4)1.76%
Revenue beat(8)5
Avg Revenue beat(8)5.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 406
Fwd PE 21.21
P/S 1.05
P/FCF 23.26
P/OCF 23.13
P/B 15.7
P/tB 15.7
EV/EBITDA 33.03
EPS(TTM)0.02
EY0.25%
EPS(NY)0.38
Fwd EY4.71%
FCF(TTM)0.35
FCFY4.3%
OCF(TTM)0.35
OCFY4.32%
SpS7.76
BVpS0.52
TBVpS0.52
PEG (NY)1.16
PEG (5Y)N/A
Graham Number0.48
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 3.73%
ROCE 27.03%
ROIC 18.6%
ROICexc N/A
ROICexgc N/A
OM 2.48%
PM (TTM) 0.25%
GM 86.01%
FCFM 4.5%
ROA(3y)-21.66%
ROA(5y)-43.55%
ROE(3y)-61.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y0.47%
F-Score6
Asset Turnover4.39
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 0.68
Debt/EBITDA 1.15
Cap/Depr 21.49%
Cap/Sales 0.03%
Interest Coverage 250
Cash Conversion 174.31%
Profit Quality 1809.86%
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 6.38
F-Score6
WACC7.56%
ROIC/WACC2.46
Cap/Depr(3y)139.61%
Cap/Depr(5y)87.28%
Cap/Sales(3y)0.14%
Cap/Sales(5y)0.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1133.93%
EPS Next Y350%
EPS Next 2Y487.37%
EPS Next 3Y214.14%
EPS Next 5YN/A
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.71%
Revenue growth 5Y26.65%
Sales Q2Q%-0.58%
Revenue Next Year5.03%
Revenue Next 2Y5.88%
Revenue Next 3Y5.64%
Revenue Next 5YN/A
EBIT growth 1Y161.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year529%
EBIT Next 3Y134.77%
EBIT Next 5YN/A
FCF growth 1Y131.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.05%
OCF growth 3YN/A
OCF growth 5YN/A

CODERE ONLINE LUXEMBOURG SA / CDRO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CODERE ONLINE LUXEMBOURG SA?

ChartMill assigns a fundamental rating of 5 / 10 to CDRO.


What is the valuation status of CODERE ONLINE LUXEMBOURG SA (CDRO) stock?

ChartMill assigns a valuation rating of 3 / 10 to CODERE ONLINE LUXEMBOURG SA (CDRO). This can be considered as Overvalued.


How profitable is CODERE ONLINE LUXEMBOURG SA (CDRO) stock?

CODERE ONLINE LUXEMBOURG SA (CDRO) has a profitability rating of 3 / 10.


Can you provide the financial health for CDRO stock?

The financial health rating of CODERE ONLINE LUXEMBOURG SA (CDRO) is 7 / 10.